XML 37 R26.htm IDEA: XBRL DOCUMENT v3.21.2
Note 2 - Summary of Significant Accounting Policies 1 (Details Textual)
$ in Thousands, € in Millions
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 10, 2021
USD ($)
Jan. 29, 2021
USD ($)
Jan. 12, 2021
USD ($)
Jun. 30, 2021
USD ($)
Mar. 31, 2021
USD ($)
Jun. 30, 2020
USD ($)
Jun. 30, 2021
USD ($)
Jun. 30, 2021
EUR (€)
Jun. 30, 2020
USD ($)
Dec. 31, 2020
USD ($)
Retained Earnings (Accumulated Deficit), Ending Balance       $ (753,424)     $ (753,424)     $ (722,912)
Working Capital       165,700     165,700      
Proceeds from Warrant Exercises             30,600      
Cash and Cash Equivalents, at Carrying Value, Ending Balance       157,078     157,078     16,363
Restricted Cash and Cash Equivalents, Noncurrent, Total       1,000     1,000     1,200
Accounts Receivable, Allowance for Credit Loss, Ending Balance       1,700     1,700     1,800
Impairment of Intangible Assets, Finite-lived       0   $ 0 0   $ 0  
Business Combination, Contingent Consideration, Liability, Total       4,671     $ 4,671     3,936
Period Of Service Sale Arrangement (Year)             5 years 5 years    
Period of Service Sale Arrangement at Stated Service Price (Year)             4 years 4 years    
Operating Lease, Lease Income, Total       300   100 $ 700   200  
Revenue, Remaining Performance Obligation, Amount       3,200     3,200     3,100
Contract with Customer, Asset, after Allowance for Credit Loss, Current, Total       100     100     100
Contract with Customer, Liability, Revenue Recognized       200   400 400   600  
Inventory Write-down       200   0 288   0  
Share-based Payment Arrangement, Expense       1,800   1,900 $ 3,600   3,900  
Number of Operating Segments             1 1    
Assets, Total       212,004     $ 212,004     78,258
Non-US [Member]                    
Assets, Total       47,600     47,600     $ 56,800
Senhance Surgical Robotic System Acquisition[Member]                    
Business Combination, Contingent Consideration, Liability, Total       4,700     $ 4,700      
Paycheck Protection Program CARES Act [Member]                    
Debt Instrument, Decrease, Forgiveness $ 2,800                  
Minimum [Member] | Senhance Surgical Robotic System Acquisition[Member]                    
Business Combination Contingent Consideration Arrangements Target Revenue | €               € 25    
Patents [Member]                    
Finite-Lived Intangible Asset, Useful Life (Year)             10 years 10 years    
Developed Technology Rights [Member] | Minimum [Member]                    
Finite-Lived Intangible Asset, Useful Life (Year)             5 years 5 years    
Developed Technology Rights [Member] | Maximum [Member]                    
Finite-Lived Intangible Asset, Useful Life (Year)             7 years 7 years    
Intellectual Property [Member]                    
Impairment of Intangible Assets, Finite-lived       $ 0   $ 0 $ 0   $ 0  
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Four Customers [Member]                    
Number of Major Customers             4 4    
Concentration Risk, Percentage             59.00% 59.00%    
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Seven Customers [Member]                    
Number of Major Customers                   7
Concentration Risk, Percentage                   68.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Seven Customers [Member]                    
Number of Major Customers           7 4 4 9  
Concentration Risk, Percentage           60.00% 54.00% 54.00% 65.00%  
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Five Customers [Member]                    
Number of Major Customers       5            
Concentration Risk, Percentage       39.00%            
Revenue Benchmark [Member] | Geographic Concentration Risk [Member] | UNITED STATES                    
Concentration Risk, Percentage       25.00%   24.00% 17.00% 17.00% 25.00%  
Revenue Benchmark [Member] | Geographic Concentration Risk [Member] | Europe [Member]                    
Concentration Risk, Percentage       53.00%   56.00% 32.00% 32.00% 52.00%  
Revenue Benchmark [Member] | Geographic Concentration Risk [Member] | Asia [Member]                    
Concentration Risk, Percentage       22.00%   20.00% 51.00% 51.00% 23.00%  
Assets, Total [Member] | Geographic Concentration Risk [Member] | UNITED STATES                    
Concentration Risk, Percentage             77.00% 77.00%   27.00%
Assets, Total [Member] | Geographic Concentration Risk [Member] | Non-US [Member]                    
Concentration Risk, Percentage             23.00% 23.00%   73.00%
Long-lived Assets [Member] | Geographic Concentration Risk [Member] | UNITED STATES                    
Concentration Risk, Percentage             21.00% 21.00%   11.00%
Long-lived Assets [Member] | Geographic Concentration Risk [Member] | ITALY                    
Concentration Risk, Percentage             37.00% 37.00%   48.00%
Long-lived Assets [Member] | Geographic Concentration Risk [Member] | SWITZERLAND                    
Concentration Risk, Percentage             40.00% 40.00%   41.00%
Public Offering [Member]                    
Proceeds from Issuance of Common Stock   $ 79,600     $ 73,400          
Registered Direct Offering [Member]                    
Proceeds from Issuance of Common Stock     $ 28,600   28,600          
ATM Offering [Member]                    
Proceeds from Issuance of Common Stock       $ 1,000 $ 27,300